Previous close | 103.85 |
Open | 104.98 |
Bid | 111.82 x 1100 |
Ask | 113.94 x 1000 |
Day's range | 103.65 - 107.59 |
52-week range | 62.55 - 163.24 |
Volume | |
Avg. volume | 4,620,865 |
Market cap | 39.835B |
Beta (5Y monthly) | 1.60 |
PE ratio (TTM) | N/A |
EPS (TTM) | -12.33 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 120.70 |
Moderna (MRNA) concluded the recent trading session at $104.26, signifying a +0.39% move from its prior day's close.
Moving away from a one-size-fits-all approach has been key.
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]